Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

NCT01285388 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Syndrome
Obesity

Interventions

DRUG: MB12066

Sponsor

Yungjin Pharm. Co., Ltd.

Collaborators

[object Object]